The increasing resistance of bacteria to antibiotics has underscored the need for new drugs or vaccines to prevent bacterial infections. Reducing multidrug resistance is a key objective of the WHO’s One Health initiative. Epitopes, the key parts of antigen molecules that determine their specificity, directly stimulate the body to produce specific humoral and/or cellular immune responses. Epitope-based vaccines, which combine dominant epitopes in a rational manner, induce a more efficient and specific immune response than the original antigen. While these vaccines face significant challenges, such as epitope escape or low immunogenicity, they offer advantages including minimal adverse reactions, improved efficacy, and optimized protection. As a result, epitope-based vaccines are considered a promising next-generation approach to combating bacterial infections. This review summarizes the latest advancements, challenges, and future prospects of epitope-based vaccines targeting bacteria, with a focus on their development workflow and application in antibiotic-resistant pathogens with high mortality rates, including Staphylococcus aureus, Streptococcus pneumoniae, Streptococcus pyogenes, Klebsiella pneumoniae, Acinetobacter baumannii, and Pseudomonas aeruginosa. The goal of this review is to provide insights into next-generation vaccination strategies to combat bacterial infections associated with antibiotic resistance and high mortality rates.
Fluorescent carbon dots (CDs) have a variety of biomedical applications such as bio-imaging. Successful application of CDs in clinic greatly depends on their biocompatibility and favorable bio-functions. In the present study, we report a facile and efficient method to synthesize a CDs-based nanohybrid bearing a multi-hydroxy hyperbranched polyglycerol (HPG) shell by combing a “grafting from” method with an anionic ring-opening polymerization technique. The resultant CDs-g-HPG had high water-dispersibility, low cytotoxicity, improved hemocompatibility and strong green fluorescence. The results demonstrate that the CDs-g-HPG possesses promising potential for bio-imaging.
Membranes with versatile separation capacity and strong chemical resistance are necessary for organic solvent nanofiltration (OSN). Here, a molecular sieving nanofilm with Janus pore structures was synthesized by introducing alkyl (–CH2–) moieties into the hydrophilic cross-linked polyamide network. In situ interfacial polymerization between m-xylylenediamine (m-XDA) and trimesoyl chloride (TMC) monomers was manipulated on a solvent-resistant nanofibrous hydrogel substrate. By varying monomer concentrations, thin film composite (TFC) OSN membranes were achieved with tuneable nanofilm thickness and hydrophobicity. Janus pathways in the m-XDA/TMC molecular sieving nanofilm contribute to a high solvent permeability for both polar and non-polar solvents; for example, for acetone the permeability is 8.2–54.5 L m−2 h−1 bar−1, for n-hexane 0.6–2.6 L m−2 h−1 bar−1, and for toluene 4.2 L m−2 h−1 bar−1. The composite membrane revealed a molecular weight cut-off of 242–327 g mol−1 in both acetone and methanol. Moreover, the membrane exhibited chemical and structural stability after immersing it in both strongly acidic or strongly basic environments for 15 days. This outstanding chemical stability, combined with the excellent permeability and selectivity, makes the m-XDA/TMC composite membrane a promising candidate for versatile OSN applications in polar and non-polar solvents as well as under extreme conditions.
Pathogenic streptococcal species are responsible for a broad spectrum of human diseases ranging from non-invasive and localized infections to more aggressive and life-threatening diseases, which cause great economic losses worldwide. Streptococci possess a dozen two-component systems (TCSs) that play important roles in the response to different environmental changes and adjust the expression of multiple genes to successfully colonize and infect host cells. In this review, we discuss the progress in the study of a conserved TCS named CiaRH in pathogenic or opportunistic streptococci including Streptococcus pneumoniae, Streptococcus pyogenes, Streptococcus agalactiae, Streptococcus mutans, Streptococcus gordonii, Streptococcus sanguinis, and Streptococcus suis, focusing on the function and regulatory networks of CiaRH, which will provide a promising strategy for the exploration of novel antistreptococcal therapies. This review highlights the important role of CiaRH and provides an important basis for the development of antistreptococcal drugs and vaccines.